Forbius, a clinical-stage company developing biologics for the treatment of fibrosis and cancer, announced today that Ilia Tikhomirov, CEO of Forbius, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference. Mr. Tikhomirov’s presentation will take place Wednesday, January 9th at 11:30 a.m. PST in Elizabethan D at the Westin St. Francis Hotel in San Francisco.
